Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 7, 2024Progress in Pediatric CardiologyOpen Access

Lipoprotein(a) in atherosclerotic cardiovascular disease, type 2 diabetes, and liver disease

View Full Paper
Ask AI
Bookmark
Share

Why the study?

The article aims to review lipoprotein(a) biology, its associations with disease, treatment, and the potential value of pediatric screening.

Design

Review article

Authors

MAMolly AugustineESEru SujakhuJMJustine Magadia

Discussion

Loading...

Member takes

Overview

Lp(a) may inform early pediatric CVD risk; leaves open evidence-based screening and intervention guidelines.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Augustine et al. (2024) studied this question.

synapsesocial.com/papers/6a7d1ff53575152c8237d0d7https://doi.org/10.1016/j.ppedcard.2024.101775
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Associations of very low Lipoprotein(a) levels with risks of new-onset diabetes and non-alcoholic liver disease2024 · 11 citations
  2. 2Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society2014 · 1,077 citations
  3. 3Nonalcoholic Fatty Liver Disease and Vascular Function2015 · 96 citations
  4. 4The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target2022 · 31 citations
  5. 5Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Has the Time Come for Cardiologists to Be Hepatologists?2012 · 104 citations